ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing
New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents
New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers
Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes
Abbott receives FDA clearance and CE Mark for next-generation Ultreon 3.0 AI-powered coronary imaging platform
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
SAGA Metals Reports Assays from R-0061 to R-0063 with Intercepts Including 47.36% Fe2O3, 6.73% TiO2, 0.353% V2O5 from 2026 Drilling at Radar Critical Minerals Project in Labrador
